Jump to main content
Jump to site search

Issue 52, 2015
Previous Article Next Article

Validation of a dual role of methotrexate-based chitosan nanoparticles in vivo

Author affiliations

Abstract

A compound with a dual role has the potential to integrate its dual functions into a single nanoscale drug delivery system. Here, based on the methotrexate (MTX)-based PEGylated chitosan (CS) nanoparticles, we validated this dual role in vivo and explored the in vivo efficiency of MTX as an early-phase tumor-targeting ligand and also as a late-phase anticancer drug. Following intravenous administration, compared with the (FA + PEG)–CS–NPs and PEG–CS–NPs, the (MTX + PEG)–CS–NPs exhibited a slower blood clearance profile, longer systemic circulation time, and significantly greater tumor accumulation. Furthermore, with the aide of folate (FA) receptor-mediated endocytosis (ability to turn cellular uptake “off” in normal cells, whereas it is “on” in cancer cells) and pH/intracellular protease-mediated hydrolyzing peptide bonds (able to turn drug release “off” in systemic circulation whereas it is “on” inside endo/lysosomes), the (MTX + PEG)–CS–NPs showed remarkably superior therapeutic efficiency compared to the commercially available MTX. More importantly, this work would stimulate interest in the use of the clinically useful MTX as a synergistically self-targeted therapeutic agent in the design of a highly convergent, flexible and simplified nanoscale drug delivery system for simultaneously targeting and treating FA receptor-overexpressing tumors.

Graphical abstract: Validation of a dual role of methotrexate-based chitosan nanoparticles in vivo

Back to tab navigation

Publication details

The article was received on 02 Mar 2015, accepted on 10 Apr 2015 and first published on 14 Apr 2015


Article type: Paper
DOI: 10.1039/C5RA03705K
Citation: RSC Adv., 2015,5, 41393-41400
  •   Request permissions

    Validation of a dual role of methotrexate-based chitosan nanoparticles in vivo

    Z. Hou, J. Lin, Y. Li, F. Guo, F. Yu, H. Wu, Z. Fan, L. Zhi and F. Luo, RSC Adv., 2015, 5, 41393
    DOI: 10.1039/C5RA03705K

Search articles by author

Spotlight

Advertisements